FK
Faisal Khurshid Leerink Partners Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
14
Avg Return
Past Year
Past Year
89%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
78.6%
Neutral
21.4%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $118 |
39%
upside
| 1 | -9.8% |
0
%
| 9 Dec ‘25 3 months ago |
|
|
|
Outperform
Maintained
| $16 |
37%
upside
| 1 | +6% |
0
%
| 20 Nov ‘25 3 months ago |
|
|
|
Market Perform
Downgraded
| $4 |
14%
upside
| 2 | +19% |
0
%
| 7 Nov ‘25 4 months ago |
|
|
|
Outperform
Upgraded
| $40 |
21%
upside
| 1 | -3.9% |
0
%
| 21 Oct ‘25 4 months ago |
|
|
|
Outperform
Initiated
| $20 |
48%
upside
| 1 | +29% |
0
%
| 25 Sep ‘25 5 months ago |
|
|
|
Outperform
Initiated
| $73 |
24%
downside
| 1 | +62% |
0
%
| 12 Sep ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $2 |
67%
downside
| 2 | +305% |
0
%
| 14 Aug ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $102 |
10%
upside
| 2 | +20% |
0
%
| 10 Jul ‘25 8 months ago |
|
|
|
Market Perform
Maintained
| $1 |
73%
downside
| 1 | – |
–
| 14 Apr ‘25 10 months ago |
|
|
|
Outperform
Initiated
| $45 |
10%
upside
| 1 | +231% |
0
%
| 8 Apr ‘25 11 months ago |
|
|
|
Market Perform
Initiated
| $16 |
3%
upside
| 1 | – |
–
| 17 Mar ‘25 11 months ago |
|